{"request":{"contents":[{"parts":[{"text":"Generate a comprehensive summary for US Code of Federal Regulations Title 21: Title 21. Include the agencies involved, the scope of regulations, and recent major changes. Use Google Search to find the most recent context and details."}],"role":"user"}],"safetySettings":[{"category":"HARM_CATEGORY_HARASSMENT","threshold":"BLOCK_NONE"},{"category":"HARM_CATEGORY_HATE_SPEECH","threshold":"BLOCK_NONE"},{"category":"HARM_CATEGORY_SEXUALLY_EXPLICIT","threshold":"BLOCK_NONE"},{"category":"HARM_CATEGORY_DANGEROUS_CONTENT","threshold":"BLOCK_NONE"}],"tools":[{"googleSearch":{"excludeDomains":[]}}]},"status":"","response":{"candidates":[{"content":{"parts":[{"text":"### US Code of Federal Regulations Title 21: A Comprehensive Overview\n\nTitle 21 of the U.S. Code of Federal Regulations (CFR) is a critical set of federal rules governing food and drugs in the United States. It provides a detailed framework to ensure the safety and efficacy of a wide range of products that consumers use daily. This summary outlines the key agencies involved in its enforcement, the broad scope of its regulations, and significant recent updates.\n\n#### **Key Enforcement Agencies**\n\nThree primary federal agencies are responsible for the administration and enforcement of the regulations outlined in Title 21:\n\n*   **Food and Drug Administration (FDA):** The FDA is the primary agency responsible for enforcing Title 21. Its authority is largely based on the Federal Food, Drug, and Cosmetic Act. The FDA regulates a vast array of products, including human and animal drugs, medical devices, food, cosmetics, and tobacco products.\n*   **Drug Enforcement Administration (DEA):** The DEA's role within Title 21 is to enforce the controlled substances laws and regulations of the United States. This includes the regulation of the manufacture, distribution, and dispensing of legally produced controlled substances.\n*   **Office of National Drug Control Policy (ONDCP):** The ONDCP is responsible for establishing policies, priorities, and objectives for the nation's drug control program. It coordinates the efforts of various federal agencies, including those involved in implementing Title 21.\n\n#### **Scope of Regulations**\n\nTitle 21 is organized into three main chapters, each corresponding to the primary enforcing agencies. The scope of these regulations is extensive and covers the entire lifecycle of regulated products, from development and manufacturing to labeling, marketing, and post-market surveillance.\n\n**Chapter I: Food and Drug Administration**\nThis is the most voluminous chapter and details the regulations for a wide array of products:\n\n*   **Food and Food Products:** This includes regulations on nutrition labeling, food additives, infant formula, and current Good Manufacturing Practices (cGMPs) for food products.\n*   **Drugs:** Regulations for both prescription and over-the-counter (OTC) drugs for human use are specified, covering areas like drug advertising, marketing, and cGMPs. It also includes requirements for new drug applications.\n*   **Biologics:** This category includes vaccines, blood and blood products, and gene therapies, with specific rules for licensing and manufacturing.\n*   **Medical Devices:** The regulations govern the design, manufacturing, packaging, labeling, and servicing of all finished medical devices intended for human use. This includes device tracking for certain high-risk devices.\n*   **Cosmetics:** While less extensive than regulations for other products, there are rules for the labeling and safety of cosmetic products.\n*   **Animal Feeds and Medications:** Title 21 also sets forth regulations for animal drugs and feeds.\n*   **Electronic Records and Signatures (21 CFR Part 11):** This crucial part establishes the criteria under which electronic records and signatures are considered trustworthy, reliable, and equivalent to paper records.\n\n**Chapter II: Drug Enforcement Administration**\nThis chapter focuses on the control of scheduled substances and outlines the requirements for:\n\n*   **Registration:** Manufacturers, distributors, and dispensers of controlled substances must register with the DEA.\n*   **Schedules of Controlled Substances:** The DEA maintains the official list of controlled substances categorized into five schedules based on their potential for abuse and medical use.\n*   **Orders for Schedule I and II Controlled Substances:** Strict procedures for the issuance, use, and preservation of order forms for these highly controlled substances are detailed.\n*   **Labeling and Packaging:** Specific requirements are set for the labeling and packaging of controlled substances.\n\n**Chapter III: Office of National Drug Control Policy**\nThis chapter pertains to the ONDCP's responsibilities, including its role in coordinating national drug control policy and activities.\n\n#### **Recent Major Changes**\n\nThe regulatory landscape of Title 21 is continuously evolving to adapt to new technologies and public health needs. Recent significant updates include:\n\n*   **Harmonization of Medical Device Quality Systems:** In a major update, the FDA issued a final rule in January 2024 to amend the Quality System (QS) Regulation for medical devices (21 CFR Part 820). This amendment incorporates by reference the international standard ISO 13485:2016, creating the new Quality Management System Regulation (QMSR). This change aims to harmonize U.S. regulations with those of other countries, promoting consistency in the global medical device market. The effective date for this new rule is February 2, 2026.\n*   **Updated Regulations for Medical Gases:** In June 2024, the FDA amended the regulations for medical gases under 21 CFR Part 213. These changes include more stringent Current Good Manufacturing Practice (CGMP) standards for the production facilities and equipment used in manufacturing medical gases to ensure their quality and safety.\n*   **Electronic Ordering of Controlled Substances:** The DEA has finalized rules to provide an electronic equivalent to the official order form for Schedule I and II controlled substances. This allows for optional electronic ordering and record-keeping, aiming to reduce paperwork and transaction times.\n*   **Proposed Changes to DEA Fees:** The DEA has proposed amendments to its regulations to codify new registration fees for business activities involving controlled substances and certain chemicals.\n*   **Technical and Conforming Amendments:** Both the FDA and DEA have made several technical amendments to various parts of Title 21 to update information, correct errors, and ensure consistency with underlying statutes. This includes updates to mailing addresses, docket numbers, and cross-references within the regulations.\n*   **ONDCP Initiatives:** The ONDCP continues to play a central role in national drug control strategy, including the establishment of a tracking and reporting system for federally funded drug-related grant programs as mandated by the SUPPORT for Patients and Communities Act."}],"role":"model"},"finishReason":"STOP","groundingMetadata":{"groundingChunks":[{"chunkMetadata":{"query":"FDA recent regulations amendments CFR Title 21"},"web":{"domain":"fda.gov","title":"fda.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1jGudHhoByrpWk7PWe31aDaY2M2PQ-aWd5Z_WSU8VEgAffmB1FT-QYntKzCWCa8Y7dl34XC7zrrCswHmv2plIxm390RAt-sydkevclvvXCJDn88x1LxUAfRFhgD7sfRdl99sdyuZLSQxzdzG1VJ96IIo_jTLRoi-BJX13JhooC9Py4YHqkjPK5XFvTNb68-OijSrcFBErh0DEniN2Z1DymuZwsc0NwyRxdQR7ff2Ori4bHo8_8PgRbxs751OwO2gTQmZVAIbDN26J9G3L4-Vd6T4Cz25BUkrPQxDtPu18np1O12KS9maXHHCMbCDnkYOO_n00Plc5aIlPH9dMu55eHid6wFj53jW2FA9ATkNNAHp7p_ZoKj51"}},{"chunkMetadata":{"query":"FDA recent regulations amendments CFR Title 21"},"web":{"domain":"ecfr.gov","title":"ecfr.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG2PWIwXR6jIk--3lYVYcmUO5v3IUElVpYS6Mwnof8PmO1iqUE1ZGP8OtHN1NUnPLy9evn5roeniqxV9QymUWjNOgJ81GAgBNOdIuu1PIM7Hp-h3esY9m8ZBNg1g45mZNM="}},{"chunkMetadata":{"query":"DEA recent rule changes CFR Title 21"},"web":{"domain":"ecfr.gov","title":"ecfr.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvb-7duuO7YFBVrQxwjyTyENWHmk9sio4J-0qUzmexRg06D6Mx79CRuuRaYthGBsZqsWfEmmuwlr-P44GJJegNqlrU2cjnhk6WPsQMQUVPz0UuTakrslFKpmpPusZ3IDZ8xgl_s2ES_PasUA=="}},{"chunkMetadata":{"query":"ONDCP recent policy updates CFR Title 21"},"web":{"domain":"whitehouse.gov","title":"whitehouse.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE5FGfHyQzxHdBvIsNg5kSEXthpaTo7nDX_jGrKx8qth2tJEj6Jrd3ZeH9Nz3gZtZdnWW1f4JJ98lOfxEmc8_m5otp7ppC68lENoQ1jXrTYh1GYmiHbUIz8mhH1GQ=="}},{"chunkMetadata":{"query":"FDA recent regulations amendments CFR Title 21"},"web":{"domain":"youtube.com","title":"youtube.com","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEvJSBZXf2FvDLOWNwtg_89GHiT67_D7CjWWfUfXDhMmCrkr4WJf9dU2DfPW_drZ8cCOFK2FbSZd1sugwI2xs0hkPkbbf3boYuKTLPKctI8eyWP6vsw8kc6LH0mai_Q6nZyNaoIifo="}},{"chunkMetadata":{"query":"FDA recent regulations amendments CFR Title 21"},"web":{"domain":"federalregister.gov","title":"federalregister.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHz8Ps_ViVHIh6-MRoMf3jA2Vh6SsTnkEkDhtu86DGyhsBHx0z6XIgi0MMtJF8jDGySJ0RRKn6M5X9qVufx6SaDpGb1scKkGNUtnwoIhusAIsvgfk1RKiiUDuCSmWJUWGDzX6WQPunH4SL_e3dez98WFBSA3PUM2tfD-nU-S9ME-iR78bFr5qHkuRpDFAHJ4-kyHFf6LX7yuKQCX0-ZPGUExvpLnj2fHvVqfqocC83B"}},{"chunkMetadata":{"query":"recent major changes to US CFR Title 21"},"web":{"domain":"federalregister.gov","title":"federalregister.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEVVzE63NtVoAHLo5rVi8pQ82PltdKK_-OjxCEVYpUqy3PxMALLPU_Z07uGQXFo48xSBQLLu3gVcDWJNIni_ncv6PHzABmPfmoUf_Fk9WhSkATxPhdjV94kt19q3CHfuxUV3B00wm4i4VpmsV-h-b9mrYSEOxOCEDADcNT1QZ11poPB5wqbMEnKXwoMq8zxvqAJgLMMb2lt-YebZjIEf7E="}},{"chunkMetadata":{"query":"DEA recent rule changes CFR Title 21"},"web":{"domain":"usdoj.gov","title":"usdoj.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGezJFNN9FmbcOCpLmhZnsdsCFPFNjFVRGnEiQUHUJU-YjNblDpuFs36WHF8fF-dGg58a5s2DliXcoGo_EjujGPc0_MoUp8WkDV0V0BIoJbBz0nKGDnyO5BwYjp-RvFFhfeBNix27Y="}},{"chunkMetadata":{"query":"DEA recent rule changes CFR Title 21"},"web":{"domain":"usdoj.gov","title":"usdoj.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGn8N92NYnM2KF69809mIBR-Dpx3-X5gcFX6xZaTvsSmI1fss_8Ec44UASBbSZz83VSD58YuDN3vu774n_rui-Tu9E5ahXZCm5fIXK6_zqa7boAsY8NhTAozZQoVRLsQAuTMF_ep9-oS00VEifFzBaCj-6YH1_F-KK5Lh35f8_Oszw-"}},{"chunkMetadata":{"query":"recent major changes to US CFR Title 21"},"web":{"domain":"ijpsjournal.com","title":"ijpsjournal.com","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGU1gc2lMQ1HPQlMNpIIItBmz9XZaxQ1oH43ADx9iAiARVw3dqE4fPIw-fdycEg8r5H10JjRbhOc6oi-jWmuMfEiuGhvE3ZRBajnE8Cwd9saVYCcFENIzPq8YkJGHb7oyVju9N2ob88MpFtqqzqDdNDZbBdcU1Imho1Hc3LKQXZRcQ0p_lVXglxor5fmjWn_VnRv2Gt-OZKAEFDCoJc7ZqyH_MjS_PAqZl-cv4u_lJoy6vFddyIUAtanOtN7FS0VDdH5LynXM6FSQ=="}},{"chunkMetadata":{"query":"DEA recent rule changes CFR Title 21"},"web":{"domain":"regulations.gov","title":"regulations.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH57rg4vAqYAMdHvQPS1PCp4a5JEZ5ewpQCnq3BFCiZVqknQa2xDnpXQ5aaOaMEmi7CA2oCURZ0VZfiFdbrechuZfAVU62g2GzxEiK2H3fzuyLllaxyELZ7U3oOonNMr59PEWXB7vHTd6svwtkP9CkTRKc="}},{"chunkMetadata":{"query":"ONDCP recent policy updates CFR Title 21"},"web":{"domain":"ecfr.gov","title":"ecfr.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE0XxGe-cPBaL0mzcPOmrRhKXqosabfww5gqw0KR_VizOKfHU1Yrs45orWUHa3vUAysWPtLKyJpFyfzfqatFwSLMOO0mD8oBlAIBsJYtcHIs8ytNSuX1hMPgRcgnMSJNqfxkvgYdHA4Ye7DJco="}},{"chunkMetadata":{"query":"recent major changes to US CFR Title 21"},"web":{"domain":"pharmaguru.co","title":"pharmaguru.co","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEPrrgxT_hQyoNSlhf7Qr58-hMOObFJRHFqvs_cMFOB66BqXS5tzWc-nsnbF8VGLv_EVtY88BnTAbLdBxGU6691N9jxIeBnUsOc9zFCYO81n6RV-1qke020H_fW5oFAnsPE6cqim814OpnxKmM_nht3SrUGyltupA=="}},{"chunkMetadata":{"query":"ONDCP recent policy updates CFR Title 21"},"web":{"domain":"whitehouse.gov","title":"whitehouse.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEXWK5YavrsjmiBD7WPKqqhoyZzkHumQFzK7AmKcuKGjz1P8ULiaB_Tb23M87pN0DxfpweJiG47WYVaZS3O4Az_rsc6AQgOcmaZlCxdArHkGcjsszFBx3axwOJ0Vd2CqeWDtRZcndfPRABkoAAY9wPvmV4="}},{"chunkMetadata":{"query":"ONDCP recent policy updates CFR Title 21"},"web":{"domain":"ecfr.io","title":"ecfr.io","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF6PzzUb5GzlE8EnjMBqp8SFFDlxVAplUCGFzN__IxxkwgTc4zYL4C7Kay4PP8nKawUBv13q8cZdsBLgF4LAFSDw4l_cb0Jjk3tbGZetb99BfTCHDTRuCwz88qKiHTKLO_XFUTLMW5_6g=="}},{"chunkMetadata":{"query":"DEA recent rule changes CFR Title 21"},"web":{"domain":"federalregister.gov","title":"federalregister.gov","uri":"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFdEqrOgbAOH9DY3AiKicCzlqJcCcyecwW345-jTgRlSA8FxUIXZKu-5I1r7an-nCBRYWdGWHdLKrE7bS6GNjWI0KEVuOAtWJ4qxRjI3rJpy-T0yivJgL1_PgC0Aeo1Q4SyvVBryIszRKoyHBrN9M_xytN9O16WWR_sPYfX6Uaen5RSHTxbFO6lJGnkc48ZGXszpcgbhr20YZC-F26Ukuy463fKLdx2JDKQ7v3laQEiji_bYIL7vQJqDJCREnutuiI9IrkbMl6HOnDGnbGg"}}],"groundingSupports":[{"groundingChunkIndices":[0],"segment":{"endIndex":814,"startIndex":739,"text":"Its authority is largely based on the Federal Food, Drug, and Cosmetic Act."}},{"groundingChunkIndices":[0,1],"segment":{"endIndex":948,"startIndex":815,"text":"The FDA regulates a vast array of products, including human and animal drugs, medical devices, food, cosmetics, and tobacco products."}},{"groundingChunkIndices":[0,2],"segment":{"endIndex":1230,"startIndex":1110,"text":"This includes the regulation of the manufacture, distribution, and dispensing of legally produced controlled substances."}},{"groundingChunkIndices":[0,3],"segment":{"endIndex":1404,"startIndex":1231,"text":"*   **Office of National Drug Control Policy (ONDCP):** The ONDCP is responsible for establishing policies, priorities, and objectives for the nation's drug control program."}},{"groundingChunkIndices":[3],"segment":{"endIndex":1511,"startIndex":1405,"text":"It coordinates the efforts of various federal agencies, including those involved in implementing Title 21."}},{"groundingChunkIndices":[0],"segment":{"endIndex":2154,"startIndex":1974,"text":"*   **Food and Food Products:** This includes regulations on nutrition labeling, food additives, infant formula, and current Good Manufacturing Practices (cGMPs) for food products."}},{"groundingChunkIndices":[0],"segment":{"endIndex":2325,"startIndex":2155,"text":"*   **Drugs:** Regulations for both prescription and over-the-counter (OTC) drugs for human use are specified, covering areas like drug advertising, marketing, and cGMPs."}},{"groundingChunkIndices":[4],"segment":{"endIndex":2533,"startIndex":2383,"text":"*   **Biologics:** This category includes vaccines, blood and blood products, and gene therapies, with specific rules for licensing and manufacturing."}},{"groundingChunkIndices":[5,6],"segment":{"endIndex":2699,"startIndex":2534,"text":"*   **Medical Devices:** The regulations govern the design, manufacturing, packaging, labeling, and servicing of all finished medical devices intended for human use."}},{"groundingChunkIndices":[3],"segment":{"endIndex":2760,"startIndex":2700,"text":"This includes device tracking for certain high-risk devices."}},{"groundingChunkIndices":[7],"segment":{"endIndex":2903,"startIndex":2761,"text":"*   **Cosmetics:** While less extensive than regulations for other products, there are rules for the labeling and safety of cosmetic products."}},{"groundingChunkIndices":[0],"segment":{"endIndex":3006,"startIndex":2904,"text":"*   **Animal Feeds and Medications:** Title 21 also sets forth regulations for animal drugs and feeds."}},{"groundingChunkIndices":[8,9,10,11],"segment":{"endIndex":3226,"startIndex":3007,"text":"*   **Electronic Records and Signatures (21 CFR Part 11):** This crucial part establishes the criteria under which electronic records and signatures are considered trustworthy, reliable, and equivalent to paper records."}},{"groundingChunkIndices":[2],"segment":{"endIndex":3490,"startIndex":3372,"text":"*   **Registration:** Manufacturers, distributors, and dispensers of controlled substances must register with the DEA."}},{"groundingChunkIndices":[12],"segment":{"endIndex":3679,"startIndex":3491,"text":"*   **Schedules of Controlled Substances:** The DEA maintains the official list of controlled substances categorized into five schedules based on their potential for abuse and medical use."}},{"groundingChunkIndices":[2],"segment":{"endIndex":3865,"startIndex":3680,"text":"*   **Orders for Schedule I and II Controlled Substances:** Strict procedures for the issuance, use, and preservation of order forms for these highly controlled substances are detailed."}},{"groundingChunkIndices":[13],"segment":{"endIndex":3984,"startIndex":3866,"text":"*   **Labeling and Packaging:** Specific requirements are set for the labeling and packaging of controlled substances."}},{"groundingChunkIndices":[11,14],"segment":{"endIndex":4176,"startIndex":3986,"text":"**Chapter III: Office of National Drug Control Policy**\nThis chapter pertains to the ONDCP's responsibilities, including its role in coordinating national drug control policy and activities."}},{"groundingChunkIndices":[0,5],"segment":{"endIndex":4564,"startIndex":4362,"text":"*   **Harmonization of Medical Device Quality Systems:** In a major update, the FDA issued a final rule in January 2024 to amend the Quality System (QS) Regulation for medical devices (21 CFR Part 820)."}},{"groundingChunkIndices":[5],"segment":{"endIndex":4905,"startIndex":4848,"text":"The effective date for this new rule is February 2, 2026."}},{"groundingChunkIndices":[9],"segment":{"endIndex":5039,"startIndex":4906,"text":"*   **Updated Regulations for Medical Gases:** In June 2024, the FDA amended the regulations for medical gases under 21 CFR Part 213."}},{"groundingChunkIndices":[9],"segment":{"endIndex":5245,"startIndex":5040,"text":"These changes include more stringent Current Good Manufacturing Practice (CGMP) standards for the production facilities and equipment used in manufacturing medical gases to ensure their quality and safety."}},{"groundingChunkIndices":[8],"segment":{"endIndex":5435,"startIndex":5246,"text":"*   **Electronic Ordering of Controlled Substances:** The DEA has finalized rules to provide an electronic equivalent to the official order form for Schedule I and II controlled substances."}},{"groundingChunkIndices":[8],"segment":{"endIndex":5550,"startIndex":5436,"text":"This allows for optional electronic ordering and record-keeping, aiming to reduce paperwork and transaction times."}},{"groundingChunkIndices":[10],"segment":{"endIndex":5750,"startIndex":5551,"text":"*   **Proposed Changes to DEA Fees:** The DEA has proposed amendments to its regulations to codify new registration fees for business activities involving controlled substances and certain chemicals."}},{"groundingChunkIndices":[15,6],"segment":{"endIndex":5972,"startIndex":5751,"text":"*   **Technical and Conforming Amendments:** Both the FDA and DEA have made several technical amendments to various parts of Title 21 to update information, correct errors, and ensure consistency with underlying statutes."}},{"groundingChunkIndices":[15,6],"segment":{"endIndex":6077,"startIndex":5973,"text":"This includes updates to mailing addresses, docket numbers, and cross-references within the regulations."}},{"groundingChunkIndices":[13],"segment":{"endIndex":6355,"startIndex":6078,"text":"*   **ONDCP Initiatives:** The ONDCP continues to play a central role in national drug control strategy, including the establishment of a tracking and reporting system for federally funded drug-related grant programs as mandated by the SUPPORT for Patients and Communities Act."}}],"retrievalMetadata":{},"searchEntryPoint":{"renderedContent":"<style>\n.container {\n  align-items: center;\n  border-radius: 8px;\n  display: flex;\n  font-family: Google Sans, Roboto, sans-serif;\n  font-size: 14px;\n  line-height: 20px;\n  padding: 8px 12px;\n}\n.chip {\n  display: inline-block;\n  border: solid 1px;\n  border-radius: 16px;\n  min-width: 14px;\n  padding: 5px 16px;\n  text-align: center;\n  user-select: none;\n  margin: 0 8px;\n  -webkit-tap-highlight-color: transparent;\n}\n.carousel {\n  overflow: auto;\n  scrollbar-width: none;\n  white-space: nowrap;\n  margin-right: -12px;\n}\n.headline {\n  display: flex;\n  margin-right: 4px;\n}\n.gradient-container {\n  position: relative;\n}\n.gradient {\n  position: absolute;\n  transform: translate(3px, -9px);\n  height: 36px;\n  width: 9px;\n}\n@media (prefers-color-scheme: light) {\n  .container {\n    background-color: #fafafa;\n    box-shadow: 0 0 0 1px #0000000f;\n  }\n  .headline-label {\n    color: #1f1f1f;\n  }\n  .chip {\n    background-color: #ffffff;\n    border-color: #d2d2d2;\n    color: #5e5e5e;\n    text-decoration: none;\n  }\n  .chip:hover {\n    background-color: #f2f2f2;\n  }\n  .chip:focus {\n    background-color: #f2f2f2;\n  }\n  .chip:active {\n    background-color: #d8d8d8;\n    border-color: #b6b6b6;\n  }\n  .logo-dark {\n    display: none;\n  }\n  .gradient {\n    background: linear-gradient(90deg, #fafafa 15%, #fafafa00 100%);\n  }\n}\n@media (prefers-color-scheme: dark) {\n  .container {\n    background-color: #1f1f1f;\n    box-shadow: 0 0 0 1px #ffffff26;\n  }\n  .headline-label {\n    color: #fff;\n  }\n  .chip {\n    background-color: #2c2c2c;\n    border-color: #3c4043;\n    color: #fff;\n    text-decoration: none;\n  }\n  .chip:hover {\n    background-color: #353536;\n  }\n  .chip:focus {\n    background-color: #353536;\n  }\n  .chip:active {\n    background-color: #464849;\n    border-color: #53575b;\n  }\n  .logo-light {\n    display: none;\n  }\n  .gradient {\n    background: linear-gradient(90deg, #1f1f1f 15%, #1f1f1f00 100%);\n  }\n}\n</style>\n<div class=\"container\">\n  <div class=\"headline\">\n    <svg class=\"logo-light\" width=\"18\" height=\"18\" viewBox=\"9 9 35 35\" fill=\"none\" xmlns=\"http://www.w3.org/2000/svg\">\n      <path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M42.8622 27.0064C42.8622 25.7839 42.7525 24.6084 42.5487 23.4799H26.3109V30.1568H35.5897C35.1821 32.3041 33.9596 34.1222 32.1258 35.3448V39.6864H37.7213C40.9814 36.677 42.8622 32.2571 42.8622 27.0064V27.0064Z\" fill=\"#4285F4\"/>\n      <path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M26.3109 43.8555C30.9659 43.8555 34.8687 42.3195 37.7213 39.6863L32.1258 35.3447C30.5898 36.3792 28.6306 37.0061 26.3109 37.0061C21.8282 37.0061 18.0195 33.9811 16.6559 29.906H10.9194V34.3573C13.7563 39.9841 19.5712 43.8555 26.3109 43.8555V43.8555Z\" fill=\"#34A853\"/>\n      <path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M16.6559 29.8904C16.3111 28.8559 16.1074 27.7588 16.1074 26.6146C16.1074 25.4704 16.3111 24.3733 16.6559 23.3388V18.8875H10.9194C9.74388 21.2072 9.06992 23.8247 9.06992 26.6146C9.06992 29.4045 9.74388 32.022 10.9194 34.3417L15.3864 30.8621L16.6559 29.8904V29.8904Z\" fill=\"#FBBC05\"/>\n      <path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M26.3109 16.2386C28.85 16.2386 31.107 17.1164 32.9095 18.8091L37.8466 13.8719C34.853 11.082 30.9659 9.3736 26.3109 9.3736C19.5712 9.3736 13.7563 13.245 10.9194 18.8875L16.6559 23.3388C18.0195 19.2636 21.8282 16.2386 26.3109 16.2386V16.2386Z\" fill=\"#EA4335\"/>\n    </svg>\n    <svg class=\"logo-dark\" width=\"18\" height=\"18\" viewBox=\"0 0 48 48\" xmlns=\"http://www.w3.org/2000/svg\">\n      <circle cx=\"24\" cy=\"23\" fill=\"#FFF\" r=\"22\"/>\n      <path d=\"M33.76 34.26c2.75-2.56 4.49-6.37 4.49-11.26 0-.89-.08-1.84-.29-3H24.01v5.99h8.03c-.4 2.02-1.5 3.56-3.07 4.56v.75l3.91 2.97h.88z\" fill=\"#4285F4\"/>\n      <path d=\"M15.58 25.77A8.845 8.845 0 0 0 24 31.86c1.92 0 3.62-.46 4.97-1.31l4.79 3.71C31.14 36.7 27.65 38 24 38c-5.93 0-11.01-3.4-13.45-8.36l.17-1.01 4.06-2.85h.8z\" fill=\"#34A853\"/>\n      <path d=\"M15.59 20.21a8.864 8.864 0 0 0 0 5.58l-5.03 3.86c-.98-2-1.53-4.25-1.53-6.64 0-2.39.55-4.64 1.53-6.64l1-.22 3.81 2.98.22 1.08z\" fill=\"#FBBC05\"/>\n      <path d=\"M24 14.14c2.11 0 4.02.75 5.52 1.98l4.36-4.36C31.22 9.43 27.81 8 24 8c-5.93 0-11.01 3.4-13.45 8.36l5.03 3.85A8.86 8.86 0 0 1 24 14.14z\" fill=\"#EA4335\"/>\n    </svg>\n    <div class=\"gradient-container\"><div class=\"gradient\"></div></div>\n  </div>\n  <div class=\"carousel\">\n    <a class=\"chip\" href=\"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcgcXsk8ZdV8zmoHIABFfuJdGtyE7Jvuxuzb-HDPza9zeGUt-xhcRgjMdi08rnhqisBp3EdqNn30IQT6dDqFKchzdcqvtYh6UY8NKAj_4AVZ_QBZcrsIbuIyl9Vt1j2HnTKs4ED1CK60Xm8DymSgWdIccDFgJhJgIm1ImMKAiUKsVWAT_NeFgT_HVQtC8ZHhGCOpE6v-m5T-xvYdC_wkzHUiEEP94IWw==\">DEA recent rule changes CFR Title 21</a>\n    <a class=\"chip\" href=\"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFXPc5PZVh2hskgx6E46YwyxAwxYvP2lZhRzPuZjfZYq4RYydesa9DvsQNtnRN4AVRP6rKfkJH_sV3NQuX4oY-5XS4wtk2pQig2OjMfJs_NVzsDovIIs3T9PE1Wom0nKgU5H5BI-0tANCMdX9ZpUF0IN-u9JH7ZQVdHw4XhbHeB8u0aGTeaC1kW-4yEGP3yTcgn_PDdkPZS883cFRcvw5-r2SUTWGvnM41jQg==\">recent major changes to US CFR Title 21</a>\n    <a class=\"chip\" href=\"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGsOE0nFAnseMu-u9FjfRUyE3IJZmyGLwQSkBnm3qk4thY4NYIRDEcux607uiZCUHkPTv7_zlcurBye18XgqjU7ORMm63dp0_9pkDmOsexe4WJOV4Q0YWDF-3TeZFwRDgWr6Ml520rnw_liFfVNnQS1oncDBd5DV67Lv6zwrINE6y0cQiK-XBlS4hsqph6PhNhHIsJMgBP1NDNkQGgZf88FdIkRz3hYCmbnGO1Hy7Toa0=\">FDA recent regulations amendments CFR Title 21</a>\n    <a class=\"chip\" href=\"https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuaJ_8PzBlXtOTy4bXUO6nEV_MicRqJeVqnRZwwGpNLJtOa0YrxBtO_bu_Tcf3SE2YzGoUk1cMux5HC186EUvqWX3sNwImNZ9KPQKOBQFluPSD-Fdm3wZm1S3tJ03tTwxeEbI9_npS3KWyOAiLmA0zC6eXSZ-J2nqxIUNWLN1HRBmNX8a1tTTtmi4AUkM4cMMV3hu7kCKqK2uGEunNU3I9kCmAHmub25y7zD4=\">ONDCP recent policy updates CFR Title 21</a>\n  </div>\n</div>\n"},"webSearchQueries":["agencies involved in enforcing CFR Title 21","scope of regulations CFR Title 21","US Code of Federal Regulations Title 21 summary","recent major changes to CFR Title 21","CFR Title 21 electronic records and signatures","CFR Title 21 scope of regulations for food and drugs","CFR Title 21 scope of regulations for cosmetics and medical devices","CFR Title 21 scope of regulations for controlled substances","FDA recent regulations amendments CFR Title 21","recent major changes to US CFR Title 21","DEA recent rule changes CFR Title 21","ONDCP recent policy updates CFR Title 21"]},"safetyRatings":[{"category":"HARM_CATEGORY_HATE_SPEECH","probability":"NEGLIGIBLE","probabilityScore":2.0014002e-05,"severity":"HARM_SEVERITY_NEGLIGIBLE","severityScore":0.02458316},{"category":"HARM_CATEGORY_DANGEROUS_CONTENT","probability":"NEGLIGIBLE","probabilityScore":0.00083079207,"severity":"HARM_SEVERITY_NEGLIGIBLE"},{"category":"HARM_CATEGORY_HARASSMENT","probability":"NEGLIGIBLE","probabilityScore":1.7026712e-05,"severity":"HARM_SEVERITY_NEGLIGIBLE","severityScore":0.06712633},{"category":"HARM_CATEGORY_SEXUALLY_EXPLICIT","probability":"NEGLIGIBLE","probabilityScore":5.818438e-06,"severity":"HARM_SEVERITY_NEGLIGIBLE"}]}],"createTime":"2025-11-24T17:17:14.111614Z","modelVersion":"gemini-2.5-pro","responseId":"GpMkaf7nBtKjgLUPxqSX-Qo","usageMetadata":{"billablePromptUsage":{"textCount":197},"candidatesTokenCount":1233,"candidatesTokensDetails":[{"modality":"TEXT","tokenCount":1233}],"promptTokenCount":47,"promptTokensDetails":[{"modality":"TEXT","tokenCount":47}],"thoughtsTokenCount":696,"toolUsePromptTokenCount":770,"toolUsePromptTokensDetails":[{"modality":"TEXT","tokenCount":770}],"totalTokenCount":2746,"trafficType":"ON_DEMAND"}},"processed_time":"2025-11-24T17:18:05.018789+00:00"}
